Intellia Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Intellia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Intellia Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intellia Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $9.3M | 540k | 17.27 |
| 2025-06-30 | $2.2M | 238k | 9.38 |
| 2025-03-31 | $2.5M | 358k | 7.11 |
| 2024-12-31 | $3.2M | 278k | 11.66 |
| 2024-09-30 | $4.1M | 201k | 20.55 |
| 2024-06-30 | $4.5M | 202k | 22.38 |
| 2024-03-31 | $5.9M | 216k | 27.51 |
| 2023-12-31 | $6.2M | 203k | 30.49 |
| 2023-09-30 | $7.2M | 227k | 31.57 |
| 2023-06-30 | $7.6M | 187k | 40.78 |
| 2022-12-31 | $2.4M | 70k | 34.89 |
| 2022-09-30 | $7.5M | 135k | 55.67 |
| 2022-06-30 | $3.9M | 75k | 51.77 |
| 2022-03-31 | $7.2M | 99k | 72.66 |
| 2021-12-31 | $15M | 129k | 118.55 |
| 2021-09-30 | $17M | 129k | 134.14 |
| 2021-06-30 | $19M | 115k | 161.93 |
| 2021-03-31 | $10M | 126k | 80.26 |
| 2020-12-31 | $8.4M | 155k | 54.41 |
| 2020-09-30 | $1.3M | 67k | 19.88 |
| 2020-06-30 | $2.3M | 110k | 21.00 |
| 2020-03-31 | $986k | 81k | 12.21 |
| 2019-12-31 | $906k | 62k | 14.65 |
| 2019-09-30 | $737k | 55k | 13.36 |
| 2019-06-30 | $855k | 52k | 16.37 |
| 2019-03-31 | $792k | 46k | 17.07 |
| 2018-12-31 | $461k | 34k | 13.63 |
| 2018-09-30 | $1.8M | 63k | 28.61 |
| 2018-06-30 | $2.0M | 71k | 27.34 |
| 2018-03-31 | $1.7M | 79k | 21.06 |
| 2017-12-31 | $669k | 35k | 19.23 |
| 2017-06-30 | $482k | 30k | 15.96 |
| 2017-03-31 | $154k | 11k | 14.04 |
| 2016-12-31 | $43k | 3.3k | 12.92 |
| 2016-09-30 | $41k | 2.4k | 17.08 |
| 2016-06-30 | $51k | 2.4k | 21.25 |